Skoči na glavni sadržaj

Cardiologia Croatica, Vol. 17 No. 9-10, 2022.

Ostalo

https://doi.org/10.15836/ccar2022.300

A case study of Impella implementation in the University Hospital Centre Rijeka on a 51-year-old male patient with acute coronary infarction

Lea Saftić orcid id orcid.org/0000-0002-3157-1143
Ružica Višnjovski orcid id orcid.org/0000-0002-9496-0680
Dajana Bura-Nekić orcid id orcid.org/0000-0002-1659-1816
Marijan Krpan orcid id orcid.org/0000-0003-2672-0746

Puni tekst: engleski pdf 125 Kb

str. 300-300

preuzimanja: 113

citiraj

Preuzmi JATS datoteku

Sažetak

Ključne riječi

Impella; acute myocardial infarction; cardiogenic shock

Hrčak ID:

289819

URI

https://hrcak.srce.hr/289819

Datum izdavanja:

8.12.2022.

Posjeta: 291 *

Copyright: 2022, Croatian Cardiac Society

Date received: 02 November 2022

Date accepted: 10 November 2022

Publication date (print and electronic): November 2022

Volume: 17

Issue: 9-10

Page: 300

Publisher ID: CC 2022 17_9-10_300

DOI: 10.15836/ccar2022.300

Article Information (continued)

Categories:

Subject: Extended Abstract

Categories:

Subject: Acute coronary syndromes

KEYWORDS: :

KEYWORDS:

Keyword: Impella

Keyword: acute myocardial infarction

Keyword: cardiogenic shock

A case study of Impella implementation in the University Hospital Centre Rijeka on a 51-year-old male patient with acute coronary infarction

[https://orcid.org/0000-0002-3157-1143] Lea Saftić[*]

[https://orcid.org/0000-0002-9496-0680] Ružica Višnjovski

[https://orcid.org/0000-0002-1659-1816] Dajana Bura-Nekić

[https://orcid.org/0000-0003-2672-0746] Marijan Krpan

 

University Hospital Centre Rijeka, Rijeka, Croatia

Author notes:

Correspondence to: [*] ADDRESS FOR CORRESPONDENCE: Lea Saftić, Klinički bolnički centar Rijeka, Ul. Tome Strižića 3, HR-51000 Rijeka, Croatia. / Phone: +385-91-300-5602 / E-mail: leasaftic@icloud.com

Acute myocardial infarction is myocardial necrosis caused by interference of the coronary artery. Acute myocardial infarction complicated by cardiogenic shock is quite rare and occurs in only 5-10% of patients who then experience critically decreased myocardial contractility and low cardiac output.

The Impella 2.5 with SmartAssist are temporary ventricular support devices and are used in only high-risk percutaneous coronary interventions (1,2). This paper presents a case study in which Impella implementation is used as a treatment in an urgent acute myocardial infarction case.

The Impella 2.5 in conjunction with an Automated Impella Controller reported a great result in the treatment of myocardial infarction complicated by cardiogenic shock in a 51-year-old patient at the University Hospital Centre Rijeka.

LITERATURE

1 

Møller JE, Kjaergaard J, Terkelsen CJ, Hassager C. Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock. J Clin Med. 2022 April 26;11(9):2427. https://doi.org/10.3390/jcm11092427 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/35566553

2 

ABIOMED. (2022) Impella 2.5® Smaller access for unloading the left ventricle. Available at:https://www.heartrecovery.com/products-and-services/impella/impella-25

This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.